Multiomics startup Pleno raises $25M for commercial launch, plucks new CEO from Illumina Pleno has plenty to talk about. | Pleno plans to launch its Raptor benchtop analyzer early next year, and it's poached Illumina's Vik Vaz to lead its commercialization.

Clever multiomics strategy to improve sensitivity and specificity for cancer and other diagnostics. #SanDiegoBiotech
#Diagnostics #Cancer #VentureCapital

PHARMA - 9 December 2024 🔊Biocon Biologics' Yesintek Receives Green Light From FDA YESINTEK™ is approved for use in Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis, offering a biosimilar option ...

Weekly Roundup - PHARMA - 9 December 2024

www.linkedin.com/pulse/pharma...

➡ kstrategyand.com/pharma-news

#BioconBiologics #Yesintek #BPZE1 #Roche #SanDiegoBiotech #PTC #Novartis #HuntingtonsDiseaseDrug #GSK #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec

Hello! Great thread! Glad to see people connecting 🥹

I’m a @ucsandiego.bsky.social HDSI postdoc studying childhood asthma! My PhD thesis was in #DevBio 👩🏽‍💻 and I’ve also worked in #SanDiegoBiotech ☀️ for large-scale drug discovery and NIPT assay dev 🧪🏢 and once upon a time was a bench scientist 👩🏽‍🔬✨